Peter Kabos

4.2k citations

100 papers · 2.5k indexed · h-index 31

Impact in

Oncology top 2%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
Cancer Research top 2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics

Papers in ⓘ

Oncology 74
- Cancer Treatment and Pharmacology 25
- HER2/EGFR in Cancer Research 25
- Cancer Cells and Metastasis 19
- Lung Cancer Research Studies 12
Cancer Research 29
- Breast Cancer Treatment Studies 15

Co-authors: Carol A. Sartorius (27 shared papers)Anthony Elias (14 shared papers)Austin E. Gillen (13 shared papers)Jessica Finlay-Schultz (13 shared papers)J. Chuck Harrell (5 shared papers)Diana M. Cittelly (11 shared papers)Kathryn B. Horwitz (5 shared papers)Manoj M. Pillai (4 shared papers)
Journals: Cancer Research (18 papers)Journal of Clinical Oncology (14 papers)Clinical Cancer Research (7 papers)Breast Cancer Research and Treatment (5 papers)Breast Cancer Research (3 papers)
Partner nations: United States Belgium Spain

In The Last Decade

Peter Kabos

96 papers receiving 2.5k citations

Peers

Countries citing papers authored by Peter Kabos

Since Specialization

Citations

This map shows the geographic impact of Peter Kabos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kabos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kabos more than expected).

Fields of papers citing papers by Peter Kabos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Kabos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kabos. The network helps show where Peter Kabos may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Kabos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Kabos Line = papers co-authored together Peter Kabos links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	ANG1005, a Brain-Penetrating Peptide–Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases Clinical Cancer Research ·Priya Kumthekar, Shou‐Ching Tang, Andrew Brenner, Santosh Kesari, David Piccioni, Carey K. Anders, Jose Carrillo, Pavani Chalasani, Peter Kabos, Shannon Puhalla, Katherine Tkaczuk, Agustin Garcia, Manmeet S. Ahluwalia, Jeffrey S. Wefel, Nehal J. Lakhani, Nuhad K. Ibrahim	2020	178
2	Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen Clinical Cancer Research ·Heather M. Brechbuhl, Jessica Finlay-Schultz, Tomomi M. Yamamoto, Austin E. Gillen, Diana M. Cittelly, Aik Choon Tan, Sharon B. Sams, Manoj M. Pillai, Anthony Elias, William A. Robinson, Carol A. Sartorius, Peter Kabos	2016	164
3	A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–Positive Breast Cancer Clinical Cancer Research ·Sara M. Tolaney, Solmaz Sahebjam, Émilie Le Rhun, Thomas Bachelot, Peter Kabos, Ahmad Awada, Denise A. Yardley, Arlene Chan, Pierfranco Conté, Véronique Dièras, Nancy U. Lin, Melissa Bear, Sonya C. Chapman, Zhengyu Yang, Yanyun Chen, Carey K. Anders	2020	144
4	Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts Proceedings of the National Academy of Sciences ·Kathryn B. Horwitz, Wendy W. Dye, J. Chuck Harrell, Peter Kabos, Carol A. Sartorius	2008	109
5	Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures Breast Cancer Research and Treatment ·Peter Kabos, Jessica Finlay-Schultz, Chunling Li, Enos Kline, Christina Finlayson, J. Wisell, Christopher A Manuel, Susan M. Edgerton, J. Chuck Harrell, Anthony Elias, Carol A. Sartorius	2012	98
6	Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers Breast Cancer Research and Treatment ·Peter Kabos, James M. Haughian, Xinshuo Wang, Wendy W. Dye, Christina Finlayson, Anthony Elias, Kathryn B. Horwitz, Carol A. Sartorius	2010	89
7	Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways Breast Cancer Research ·Ritsuko Iwanaga, Chuan Wang, Douglas S. Micalizzi, J. Chuck Harrell, Paul Jedlicka, Carol A. Sartorius, Peter Kabos, Susan M. Farabaugh, Andrew P. Bradford, Heide L. Ford	2012	79
8	Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a Oncogene ·Jessica Finlay-Schultz, Diana M. Cittelly, Peter S. Hendricks, Parul Patel, Peter Kabos, Britta M. Jacobsen, Jennifer K. Richer, Carol A. Sartorius	2014	69
9	Phase I Study of Elacestrant (RAD1901), a Novel Selective Estrogen Receptor Degrader, in ER-Positive, HER2-Negative Advanced Breast Cancer Journal of Clinical Oncology ·Aditya Bardia, Virginia Kaklamani, Sharon Wilks, Amy Weise, Donald Richards, Wael A. Harb, Cynthia R. Osborne, Robert Wesolowski, Meghan Karuturi, Paul Conkling, Rebecca G. Bagley, Yamei Wang, Maureen G. Conlan, Peter Kabos	2021	67
10	Genome-Wide Analysis of miRNA-mRNA Interactions in Marrow Stromal Cells Stem Cells ·Ilango Balakrishnan, Xiaodong Yang, Joseph Brown, Aravind Ramakrishnan, Beverly Torok‐Storb, Peter Kabos, Jay R. Hesselberth, Manoj M. Pillai	2013	66
11	HITS-CLIP reveals key regulators of nuclear receptor signaling in breast cancer Breast Cancer Research and Treatment ·Manoj M. Pillai, Austin E. Gillen, Tomomi M. Yamamoto, Enos Kline, Joseph Brown, Kale Flory, Jay R. Hesselberth, Peter Kabos	2014	63
12	A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer Breast Cancer Research ·Jennifer R. Diamond, S. Gail Eckhardt, Todd M. Pitts, Adrie van Bokhoven, Dara L. Aisner, Daniel L. Gustafson, Anna Capasso, Sharon B. Sams, Peter Kabos, Kathryn L. Zolman, Tiffany Colvin, Anthony Elias, Anna Maria Storniolo, Bryan P. Schneider, Dexiang Gao, John J. Tentler, Virginia F. Borges, Kathy D. Miller	2018	61
13	Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism Oncogene ·Carol A. Sartorius, Colton Hanna, Brunilde Gril, Heloisa Cruz, Natalie J. Serkova, Kimberly M. Huber, Peter Kabos, Troy Schedin, Virgina F Borges, Patricia S. Steeg, Diana M. Cittelly	2015	57
14	The Six1 oncoprotein downregulates p53 via concomitant regulation of RPL26 and microRNA-27a-3p Nature Communications ·Christina G. Towers, Anna L. Guarnieri, Douglas S. Micalizzi, J. Chuck Harrell, Austin E. Gillen, Jihye Kim, Chu-An Wang, Michael Oliphant, David Drasin, Michelle A. Guney, Peter Kabos, Carol A. Sartorius, Aik Choon Tan, Charles M. Perou, Joaquı́n M. Espinosa, Heide L. Ford	2015	50
15	Combination of Trastuzumab Emtansine and Stereotactic Radiosurgery Results in High Rates of Clinically Significant Radionecrosis and Dysregulation of Aquaporin-4 Clinical Cancer Research ·Priscilla K. Stumpf, Diana M. Cittelly, Tyler P. Robin, Julie A. Carlson, Kelly Stuhr, María J. Contreras‐Zárate, Steven Lai, D. Ryan Ormond, Chad G. Rusthoven, Laurie E. Gaspar, Rachel Rabinovitch, Brian D. Kavanagh, Arthur Liu, Jennifer R. Diamond, Peter Kabos, Christine M. Fisher	2019	49
16	Breast Cancer Suppression by Progesterone Receptors Is Mediated by Their Modulation of Estrogen Receptors and RNA Polymerase III Cancer Research ·Jessica Finlay-Schultz, Austin E. Gillen, Heather M. Brechbuhl, Joshua Ivie, Shawna B. Matthews, Britta M. Jacobsen, David L. Bentley, Peter Kabos, Carol A. Sartorius	2017	49
17	Abemaciclib in combination with pembrolizumab for HR+, HER2− metastatic breast cancer: Phase 1b study npj Breast Cancer ·Hope S. Rugo, Peter Kabos, Julia Beck, Guy Jérusalem, Hans Wildiers, Elena Sevillano, Luis Paz‐Ares, Michael Chisamore, Sonya C. Chapman, Anwar M. Hossain, Yanyun Chen, Sara M. Tolaney	2022	46
18	Trastuzumab emtansine and stereotactic radiosurgery: an unexpected increase in clinically significant brain edema Neuro-Oncology ·Joshua Carlson, Zohra Nooruddin, Chad G. Rusthoven, Anthony Elias, Virginia F. Borges, Jennifer R. Diamond, Brian D. Kavanagh, Peter Kabos	2014	45
19	Progesterone-Inducible Cytokeratin 5-Positive Cells in Luminal Breast Cancer Exhibit Progenitor Properties Hormones and Cancer ·Sunshine Daddario Axlund, Byong Hoon Yoo, Rachel B. Rosen, Jerome Schaack, Peter Kabos, Daniel V. LaBarbera, Carol A. Sartorius	2012	41
20	21-Gene Recurrence Score Assay As a Predictor of Adjuvant Chemotherapy Administration for Early-Stage Breast Cancer: An Analysis of Use, Therapeutic Implications, and Disparity Profile Journal of Clinical Oncology ·Jagar Jasem, Arya Amini, Rachel Rabinovitch, Virginia F. Borges, Anthony Elias, Christine M. Fisher, Peter Kabos	2016	40

About Peter Kabos

Peter Kabos is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics and Genetics, having authored 100 papers that have together received 2.5k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (39 papers), Cancer Treatment and Pharmacology (25 papers), HER2/EGFR in Cancer Research (25 papers), Cancer Cells and Metastasis (19 papers), Breast Cancer Treatment Studies (15 papers), Estrogen and related hormone effects (14 papers), Brain Metastases and Treatment (13 papers) and Lung Cancer Research Studies (12 papers). The work is most often cited by research in Oncology (1.5k citations), Cancer Research (740 citations), Genetics (271 citations), Pulmonary and Respiratory Medicine (828 citations) and Molecular Biology (1.0k citations). Peter Kabos has collaborated with scholars based in United States, Belgium and Spain. Frequent co-authors include Carol A. Sartorius, Anthony Elias, Austin E. Gillen, Jessica Finlay-Schultz, J. Chuck Harrell, Diana M. Cittelly, Kathryn B. Horwitz, Manoj M. Pillai, Wendy W. Dye and Virginia F. Borges. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Clinical Cancer Research, Breast Cancer Research and Treatment and Breast Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact